FDA grants Breakthrough Device Designation for Roche’s Elecsys Growth Differentiation Factor-15 (GDF-15) assay to help identify patients suitable for innovative treatment addressing unintentional weight loss in cancer patients

    NEXT STORY
    Global Medical Clothing Market 2021 Size & Share | Market worth USD 99.9 Billion with 5.9% CAGR by 2027
    PREV STORY
    Biosensor Market revenue to cross USD 42 Bn by 2027: Global Market Insights, Inc.
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Global Point of Care (PoC) Molecular Diagnostics Market (2020 to 2030) – by Product, Technology, Application, End-user and Region

    author_avatar
    NASDAQ Market News

    The New England Journal of Medicine Publishes Two Articles on Trogarzo™

    Phase III results and FDA-authored article featured in latest edition of NEJMMONTREAL, Aug. 15, ...

    author_avatar
    NASDAQ Market News

    Olainfarm Group’s revenue in the first quarter reaches 34.7 million EUR; net profit tops 8.3 million EUR

    author_avatar
    NASDAQ Market News